|
Volumn 96, Issue 5, 1996, Pages 297-302
|
Juvenile rheumatoid arthritis
a a b |
Author keywords
Juvenile rheumatoid arthritis; Treatment outcomes
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTINUCLEAR ANTIBODY;
ANTIRHEUMATIC AGENT;
CHOLINE MAGNESIUM TRISALICYLATE;
CORTICOSTEROID;
GOLD;
HLA B27 ANTIGEN;
HYDROXYCHLOROQUINE;
IBUPROFEN;
METHOTREXATE;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
RHEUMATOID FACTOR;
SALAZOSULFAPYRIDINE;
TOLMETIN;
ARTICLE;
BLINDNESS;
BONE MARROW TOXICITY;
DIAGNOSTIC APPROACH ROUTE;
DISEASE CLASSIFICATION;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
IRIDOCYCLITIS;
JUVENILE RHEUMATOID ARTHRITIS;
KERATOPATHY;
LIVER TOXICITY;
MANIPULATIVE MEDICINE;
NEPHROTOXICITY;
OCCUPATIONAL THERAPY;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PATIENT COUNSELING;
PHYSIOTHERAPY;
RETINA DISEASE;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
AGE OF ONSET;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, JUVENILE RHEUMATOID;
CHILD;
CHILD, PRESCHOOL;
DIAGNOSIS, DIFFERENTIAL;
DRUG THERAPY, COMBINATION;
HUMANS;
MUSCULOSKELETAL DISEASES;
PROGNOSIS;
|
EID: 28144457663
PISSN: 00986151
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (7)
|